Schechter Investment Advisors LLC Acquires Shares of 28,786 Smith & Nephew plc (NYSE:SNN)

Schechter Investment Advisors LLC bought a new stake in Smith & Nephew plc (NYSE:SNN) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 28,786 shares of the medical equipment provider’s stock, valued at approximately $785,000.

Several other institutional investors and hedge funds have also bought and sold shares of SNN. Raymond James Financial Services Advisors Inc. lifted its position in shares of Smith & Nephew by 62.8% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 12,319 shares of the medical equipment provider’s stock valued at $393,000 after buying an additional 4,750 shares during the last quarter. Citigroup Inc. lifted its position in Smith & Nephew by 13.3% during the first quarter. Citigroup Inc. now owns 70,399 shares of the medical equipment provider’s stock valued at $2,246,000 after purchasing an additional 8,284 shares during the last quarter. Sei Investments Co. grew its stake in Smith & Nephew by 27.8% in the 1st quarter. Sei Investments Co. now owns 41,743 shares of the medical equipment provider’s stock worth $1,349,000 after buying an additional 9,085 shares in the last quarter. Zions Bancorporation N.A. increased its stake in Smith & Nephew by 44.6% in the first quarter. Zions Bancorporation N.A. now owns 3,337 shares of the medical equipment provider’s stock valued at $106,000 after acquiring an additional 1,029 shares during the last quarter. Finally, Bridgewater Associates LP raised its position in Smith & Nephew by 11.7% during the first quarter. Bridgewater Associates LP now owns 131,065 shares of the medical equipment provider’s stock valued at $4,181,000 after purchasing an additional 13,717 shares in the last quarter. 25.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded Smith & Nephew from a “buy” rating to a “strong-buy” rating in a report on Friday, March 15th. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.

Smith & Nephew Trading Up 1.0 %

SNN opened at $26.33 on Thursday. Smith & Nephew plc has a 12 month low of $21.52 and a 12 month high of $33.08. The company has a current ratio of 1.77, a quick ratio of 0.72 and a debt-to-equity ratio of 0.44. The business’s 50-day moving average price is $27.60 and its 200-day moving average price is $26.09.

Smith & Nephew Announces Dividend

The company also recently announced a semi-annual dividend, which will be paid on Wednesday, May 22nd. Stockholders of record on Tuesday, April 2nd will be issued a $0.462 dividend. This represents a dividend yield of 2.8%. The ex-dividend date is Monday, April 1st.

Smith & Nephew Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.